153 related articles for article (PubMed ID: 6212595)
1. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE
J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
[TBL] [Abstract][Full Text] [Related]
2. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
[TBL] [Abstract][Full Text] [Related]
3. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
[TBL] [Abstract][Full Text] [Related]
4. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
Jones RN; Barry AL; Thornsberry C; Wilson HW
Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
[TBL] [Abstract][Full Text] [Related]
5. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
[TBL] [Abstract][Full Text] [Related]
6. Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.
Thornsberry C; Jones RN
Drugs; 1981; 22 Suppl 1():3-12. PubMed ID: 6456889
[TBL] [Abstract][Full Text] [Related]
7. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
Barry AL; Jones RN; Thornsberry C
Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
Thornsberry C; Jones RN; Barry AL; Fuchs PC
Rev Infect Dis; 1982; 4 Suppl():S316-24. PubMed ID: 6294780
[TBL] [Abstract][Full Text] [Related]
9. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
11. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH
J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of LY164846, a new oral cephalosporin, and recommendations for disk diffusion tests.
Sassine-Nawas G; Baker CN; Thornsberry C
Diagn Microbiol Infect Dis; 1987 Jan; 6(1):41-8. PubMed ID: 3100126
[TBL] [Abstract][Full Text] [Related]
15. Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.
Hardy DJ; Barry AL; Fuchs PC; Gerlach EH; McLaughlin JC; Pfaller MA
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):926-30. PubMed ID: 1486889
[TBL] [Abstract][Full Text] [Related]
16. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
[TBL] [Abstract][Full Text] [Related]
17. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
Kronvall G
J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of antibacterial activities of cephalosporins].
Kayser FH; Kohler ML
Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496
[TBL] [Abstract][Full Text] [Related]
19. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
Jones RN; Thornsberry C; Barry AL; Ayers L; Brown S; Daniel J; Fuchs PC; Gavan TL; Gerlach EH; Matsen JM
J Clin Microbiol; 1984 Sep; 20(3):409-12. PubMed ID: 6490826
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
